미국의 영상 서비스 시장 규모, 점유율, 동향 분석 보고서 : 모달리티별, 최종 용도별, 부문별 예측(2025-2030년)

U.S. Imaging Services Market Growth & Trends:

The U.S. imaging services market size is expected to reach USD 192.9 billion by 2030, registering a CAGR of 4.3% from 2025 to 2030, according to a new report by Grand View Research, Inc. The growing prevalence of various conditions, such as cancer and cardiac disorders, is expected to drive the growth. Imaging services involve different imaging modalities, such as X-rays, mammography, CT scans, nuclear medicine scans, MRI scans, and ultrasound. Each modality includes its own associated advantages of diagnosing a wide range of healthcare conditions accurately.

The adoption of imaging services in the U.S. is increasing gradually to enhance early diagnosis of the disease, which, in turn, improves its treatment options. Moreover, the growing adoption of non-invasive and cost-efficient procedures is expected to contribute to market growth. Medical imaging services consume less time in comparison to other invasive procedures and thus help reduce hospital stays and costs associated with it. Various technologies are being developed to enhance medical imaging devices by improving the image quality captured by them. These fine and sharp images help in diagnosing the disease at an early stage, thereby improving its treatment outcomes.

The number of outpatient settings in the U.S. is increasing rapidly and installation of advanced imaging devices in these settings is on the rise. As per the Organization for Economic Co-operation and Development (OECD), in 2021, 17.9 per 1,000,000 inhabitants MRI units were installed in hospitals. Moreover, the growing number of CT scans in the U.S. is expected to propel the overall market growth. As per Statista, in 2019, 279 per 1,000 inhabitants CT scans were performed in the U.S. Additionally, the low cost of CT scans in comparison to MRI is expected to drive its adoption.

Major challenges in this market include the high cost of certain modalities, such as MRI, and the side effects associated with each imaging modality. MRI scans are mainly preferred in diagnosing various conditions as they help in proper tissue differentiation. However, the average cost of the procedure in the U.S. is USD 1,430, which is high in comparison to other imaging modalities, thus hindering the overall market growth.

U.S. Imaging Services Market Report Highlights:

• Nuclear medicine scans held the largest share of 24.31% in 2024. Rising awareness levels among physicians and clinical researchers regarding the benefits of nuclear imaging scans, coupled with increasing application areas, such as cases in oncology and neurological diseases, are the factors driving the market.
• The magnetic resonance imaging segment is expected to grow at the highest CAGR of 4.7% over the forecast period.
• Hospitals held the largest share of 38.56% in 2024, owing to the increasing prevalence of various conditions such as cancer and cardiac disorders.
• Diagnostic imaging centers are expected to witness segment growth in the market due to the increasing demand for outpatient imaging services. The shift toward value-based healthcare and cost-reducing measures has led healthcare providers to prefer outpatient settings, offering lower costs and greater patient convenience.

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Modality
  • 1.1.2. End-Use
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
  • 2.2.1. Modality outlook
  • 2.2.2. End-use outlook
• 2.3. Competitive Insights

Chapter 3. U.S. Imaging Services Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
  • 3.1.2. Related/ancillary market outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Industry Value Chain Analysis
  • 3.3.1. Reimbursement framework
• 3.4. Market Dynamics
  • 3.4.1. Market driver analysis
    • 3.4.1.1. Increasing prevalence of cancer and cardiac disorders
    • 3.4.1.2. Growing number of outpatient settings with imaging services
    • 3.4.1.3. Growing awareness of medical imaging
  • 3.4.2. Market restraint analysis
    • 3.4.2.1. High cost of MRI services
    • 3.4.2.2. Side effects of imaging modalities
• 3.5. U.S. Imaging Services Market Analysis Tools
  • 3.5.1. Industry Analysis - Porter's
    • 3.5.1.1. Supplier power
    • 3.5.1.2. Buyer power
    • 3.5.1.3. Substitution threat
    • 3.5.1.4. Threat of new entrant
    • 3.5.1.5. Competitive rivalry
  • 3.5.2. PESTEL Analysis
    • 3.5.2.1. Political landscape
    • 3.5.2.2. Technological landscape
    • 3.5.2.3. Economic landscape

Chapter 4. U.S. Imaging Services Market: Modality Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. U.S. Imaging Services Modality Market Movement Analysis
• 4.3. U.S. Imaging Services Market Size & Trend Analysis, by Modality, 2018 to 2030 (USD Million)
  • 4.3.1. X-rays
    • 4.3.1.1. X-rays market estimates and forecast 2018 - 2030 (USD Billion)
  • 4.3.2. CT scans
    • 4.3.2.1. CT scans market estimates and forecast, 2018 - 2030 (USD Billion)
  • 4.3.3. Nuclear medicine scans
    • 4.3.3.1. Nuclear medicine scans market estimates and forecast, 2018 - 2030 (USD Billion)
  • 4.3.4. MRI scans
    • 4.3.4.1. MRI scans market estimates and forecast, 2018 - 2030 (USD Billion)
  • 4.3.5. Ultrasound
    • 4.3.5.1. Ultrasound market estimates and forecast, 2018 - 2030 (USD Billion)
  • 4.3.6. Mammography
    • 4.3.6.1. Mammography market estimates and forecast, 2018 - 2030 (USD Billion)

Chapter 5. U.S. Imaging Services Market: End Use Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. U.S. Imaging Services End Use Market Movement Analysis
• 5.3. U.S. Imaging Services Market Size & Trend Analysis, by End Use, 2018 to 2030 (USD Million)
  • 5.3.1. Hospitals
    • 5.3.1.1. Hospitals market estimates and forecast, 2018 - 2030 (USD Billion)
  • 5.3.2. Diagnostic imaging centers
    • 5.3.2.1. Diagnostics Imaging Centers market estimates and forecast, 2018 - 2030 (USD Billion)
  • 5.3.3. Others
    • 5.3.3.1. Others market estimates and forecast, 2018 - 2030 (USD Billion)

Chapter 6. Competitive Landscape

• 6.1. Recent Developments & Impact Analysis, By Key Market Participants
• 6.2. Company/Competition Categorization
• 6.3. Key company market share analysis, 2024
• 6.4. Company Position Analysis
• 6.5. Company Categorization (Emerging Players, Innovators and Leaders)
• 6.6. Company Profiles
  • 6.6.1. Radnet, Inc.
    • 6.6.1.1. Company overview
    • 6.6.1.2. Financial performance
    • 6.6.1.3. Product benchmarking
    • 6.6.1.4. Strategic initiatives
  • 6.6.2. Sonic Healthcare
    • 6.6.2.1. Company overview
    • 6.6.2.2. Financial performance
    • 6.6.2.3. Product benchmarking
    • 6.6.2.4. Strategic initiatives
  • 6.6.3. Dignity Health
    • 6.6.3.1. Company overview
    • 6.6.3.2. Financial performance
    • 6.6.3.3. Product benchmarking
    • 6.6.3.4. Strategic initiatives
  • 6.6.4. Novant Health
    • 6.6.4.1. Company overview
    • 6.6.4.2. Financial performance
    • 6.6.4.3. Product benchmarking
    • 6.6.4.4. Strategic initiatives
  • 6.6.5. Alliance Medical
    • 6.6.5.1. Company overview
    • 6.6.5.2. Financial performance
    • 6.6.5.3. Product benchmarking
    • 6.6.5.4. Strategic initiatives
  • 6.6.6. Inhealth Group
    • 6.6.6.1. Company overview
    • 6.6.6.2. Financial performance
    • 6.6.6.3. Product benchmarking
    • 6.6.6.4. Strategic initiatives
  • 6.6.7. Medica Group
    • 6.6.7.1. Company overview
    • 6.6.7.2. Financial performance
    • 6.6.7.3. Product benchmarking
    • 6.6.7.4. Strategic initiatives
  • 6.6.8. Global Diagnostics
    • 6.6.8.1. Company overview
    • 6.6.8.2. Financial performance
    • 6.6.8.3. Product benchmarking
    • 6.6.8.4. Strategic initiatives
  • 6.6.9. Concord Medical Services Holdings Limited
    • 6.6.9.1. Company overview
    • 6.6.9.2. Financial performance
    • 6.6.9.3. Product benchmarking
    • 6.6.9.4. Strategic initiatives
  • 6.6.10. Center for Diagnostic Imaging, Inc.
    • 6.6.10.1. Company overview
    • 6.6.10.2. Financial performance
    • 6.6.10.3. Product benchmarking
    • 6.6.10.4. Strategic initiatives
  • 6.6.11. Unilabs
    • 6.6.11.1. Company overview
    • 6.6.11.2. Financial performance
    • 6.6.11.3. Product benchmarking
    • 6.6.11.4. Strategic initiatives
  • 6.6.12. Healius Limited
    • 6.6.12.1. Company overview
    • 6.6.12.2. Financial performance
    • 6.6.12.3. Product benchmarking
    • 6.6.12.4. Strategic initiatives
  • 6.6.13. Simonmed Imaging
    • 6.6.13.1. Company overview
    • 6.6.13.2. Financial performance
    • 6.6.13.3. Product benchmarking
    • 6.6.13.4. Strategic initiatives